The new drug products under development are: raw materials and capsules of the anticancer drug "temozolomide"; Azithromycin granules, roxithromycin granules, clarithromycin tablets and other antibacterial drugs. These new drugs were first listed in Europe and America at the end of last century. They have the characteristics of wide adaptability, large demand, remarkable curative effect, high safety and low cost, so they have a very broad market prospect.